Key result
Dimethyl sulfoxide (0.1-3%) induced dose-dependent vasorelaxation in rat aorta by increasing cGMP via endothelial NO release and decreasing Ca2+ sensitivity partly via Rho-kinase inhibition.
DMSO induces vasorelaxation in rat aorta through both endothelium-dependent NO/cGMP pathways and endothelium-independent mechanisms involving decreased Ca2+ sensitivity.
No immediate clinical implications from rat data; leaves open human vascular translation.
This study examined the mechanism of vasorelaxation induced by dimethyl sulfoxide (DMSO) in endothelium-intact and -denuded rat aorta. DMSO (0.1-3%) inhibited phenylephrine (PE, 1 μmol/l)-induced contraction in a dose-dependent manner. However, this relaxation was lower in the absence of the endothelium. Increase in DMSO-induced relaxation in the presence of the endothelium was attenuated by preincubation in L-NG-nitroarginine methyl ester (L-NAME, 100 μmol/l) and by the removal of the endothelium. In the aorta with endothelium, DMSO (3%) and CCh (3 μmol/l) increased cGMP contents, significantly and L-NAME (100 μmol/l) inhibited the DMSO-induced increases of cGMP. In fura 2-loaded endothelium-denuded aorta, cumulative application of DMSO (1-3%) inhibited PE-induced muscle tension; however, this application did not affect the [Ca2+]i level. In PE-precontracted endothelium-denuded aorta, relaxation responses to fasudil were significantly less in the presence of DMSO compared to the control. These results suggest that DMSO causes relaxation by increasing the cGMP content in correlation with the release of NO from endothelial cells and by decreasing the Ca2+ sensitivity of contractile elements partly via inhibiting Rho-kinase in rat aorta.
No takes yet. Share an insight, caveat, or question.
Kaneda et al. (2016) studied this question. Dimethyl sulfoxide (DMSO) vs. Control was evaluated on Vasorelaxation and cGMP contents. Dimethyl sulfoxide (0.1-3%) induced dose-dependent vasorelaxation in rat aorta by increasing cGMP via endothelial NO release and decreasing Ca2+ sensitivity partly via Rho-kinase inhibition.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: